Orphan Drugs Market Report, Size, Share, Trends, Growth & Forecast 2020-2025

-

 According to IMARC Group’s latest report, titled “Orphan Drugs Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025,”. Looking forward, IMARC Group expects the global orphan drugs market to exhibit moderate growth during the next five years.

Orphan drugs are used to diagnose, prevent, and treat rare medical disorders. These drugs aim to meet particular public health requirements and generally have a limited production, only for a small group of patients. Orphan drugs help in treating several oncological, metabolic, hematologic, immunologic, infectious, and neurological ailments. These ailments majorly include lymphoma, leukemia, cystic fibrosis, glioma, pancreatic cancer, ovarian cancer, etc.

 Request For a Sample Report: https://www.imarcgroup.com/orphan-drugs-market/requestsample

Market Trends

The high prevalence of cancer and other rare genetic disorders is primarily driving the need for orphan drugs. Several pharma companies are focusing on developing new orphan drugs for providing personalized therapies for patients. Additionally, the higher approval rate of several pipeline drugs, along with the introduction of numerous favorable government policies to curb the spread of various infectious diseases, is also catalyzing the market growth. Moreover, extensive R&D activities for the development of biological orphan drugs that can treat cancer and minimize the damage caused to the stem cells are further expected to drive the market for orphan drugs in the coming years.

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

Some of these key players include:

  • AbbVie Inc.
  • Alexion Pharmaceuticals Inc.
  • Amgen Inc.
  • Biogen Inc.
  • Bristol-Myers Squibb Company
  • F. Hoffmann-La Roche AG (Roche Holding AG)
  • Jazz Pharmaceuticals Plc
  • Johnson & Johnson
  • Merck & Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi S.A.
  • Takeda Pharmaceutical Company Limited
  • Teva Pharmaceutical Industries Ltd.


The report has segmented the market on the basis of drug type, disease type, phase, top selling drug, distribution channel and region.

Breakup by Drug Type:

  • Biological
  • Non-Biological

Breakup by Disease Type:

  • Oncology
  • Hematology
  • Neurology
  • Cardiovascular
  • Others

Breakup by Phase:

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

Breakup by Top Selling Drugs:

  • Revlimid
  • Rituxan
  • Copaxone
  • Opdivo
  • Keytruda
  • Imbruvica
  • Avonex
  • Sensipar
  • Soliris
  • Others

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Stores
  • Others

Explore Full Content of Report: https://www.imarcgroup.com/orphan-drugs-market

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Key Highlights of the Report

  • Market Performance (2014-2019)
  • Market Outlook (2020- 2025)
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

Browse Related Report

https://www.imarcgroup.com/breast-imaging-market

https://www.imarcgroup.com/regenerative-medicine-market

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Website: https://www.imarcgroup.com/
Email: sales@imarcgroup.com
USA: +1-631-791-1145
Follow us on twitter: @imarcglobal
Linkedin: https://www.linkedin.com/company/imarc-group

Location: United States

Comments

Post a Comment

Popular posts from this blog

European Frozen Seafood Market is Projected to witness Strong Growth during the Forecast Period

-
Image
According to the latest report by IMARC Group, titled “ European Frozen Seafood Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024 ”, the  European frozen seafood market  reached a value of US$ 21.4 Billion in 2018, growing at a CAGR of 3.7% during 2011-2018. The European continent is intricately linked with the sea and seafood products form a quintessential part of the regional cuisine. These products serve as a rich source of proteins, micronutrients and essential fatty acids, and are low in fat. They are known to promote heart health, ease the symptoms of arthritis, maintain healthy eyesight, and preserve skin moisture, along with offering innumerable other health benefits. As these products are highly perishable, they require freezing for extending their shelf-life. The freezing process employs advanced techniques like cryofreezing to freeze the products below 200? C. This helps in sealing the flavor and nutrients in the food products fo...
Read more

Xylitol Market to Reach US$ 1,225 Million by 2025 , Industry Overview, Growth Rate and Forecast

-
As per the latest report by IMARC Group, titled “ Xylitol Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025 ”, the  global  xylitol market   size  reached US$ 875 Million in 2019. Xylitol is a sugar alcohol with a crystalline and granular structure and sweetness, which is comparable to sucrose. Also known as wood sugar, it is derived from xylose that occurs naturally in various fruits and vegetables. On a commercial scale, xylitol can be produced by chemical and biotechnological processes. With the rising health-consciousness, consumers are willing to spend more on natural sweeteners, such as xylitol, as it has around 75% fewer carbohydrates and 40% lesser calories as compared to table sugar. Request for a free sample copy of this report:  https://www.imarcgroup.com/xylitol-market/requestsample Global Xylitol Market Trends: Xylitol finds applications in numerous industries ranging from food and beverage (F&B...
Read more

$ 533.4 Billion Warehousing and Storage Market - Driving Factors, Key Players and Growth Opportunities by 2024

-
Image
According to the latest report by IMARC Group, titled “ Warehousing and Storage Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024 ”, the  global warehousing and storage market size  reached US$ 397.3 Billion in 2018. A warehouse refers to a storage space that is used for stocking finished and semi-finished goods, raw materials, and import and export products. Warehousing and storage services help manufacturers in protecting the goods from pests and insects as well as ensuring a smooth flow of production and distribution activities. At present, the demand for these services is experiencing a rise on account of factors such as the evolving e-commerce sector, the growing popularity of frozen food items and the emerging trend of outsourcing warehousing services. Request for a free sample copy of this report:   https://www.imarcgroup.com/warehousing-and-storage-market/requestsample Global Warehousing and Storage Market Trends: ...
Read more